FENC
Fennec Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.39
−1.27%Forward multiples
Based on analyst estimates
- P/E forward
- 21.04x
- P/E 2026E
- 41.88x
- P/E 2027E
- 13.05x
- P/E 2028E
- 7.61x
- P/S forward
- 5.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.24x
- Price / sales
- 7.34x
- Price / cash flow
- -212.98x
Enterprise value
- Enterprise value
- $393.2M
- EV / sales
- 6.64x
- EV / EBITDA
- -165.50x
- EV / EBIT
- -338.12x
- Market cap
- $434.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026